1990
Conception delay after oral contraceptive use: the effect of estrogen dose**Supported by grant HD 11357 and HD 16282 from the National Institutes for Child Health and Human Development and by grant DA 05484 from the National Institute for Drug Abuse, Bethesda, Maryland.
Bracken M, Hellenbrand K, Holford T. Conception delay after oral contraceptive use: the effect of estrogen dose**Supported by grant HD 11357 and HD 16282 from the National Institutes for Child Health and Human Development and by grant DA 05484 from the National Institute for Drug Abuse, Bethesda, Maryland. Fertility And Sterility 1990, 53: 21-27. PMID: 2295345, DOI: 10.1016/s0015-0282(16)53210-5.Peer-Reviewed Original ResearchConceptsOral contraceptive useContraceptive useFormer oral contraceptive usersConception delayFormer OC usersLower estrogen dosesOral contraceptive usersEffects of estrogenNational InstituteMethod of contraceptionEstrogen doseOC discontinuationEstrogen dosesOral contraceptionOC usersContraceptive usersChild healthProbability of conceptionHigh dosesDrug abuseMean timeDiscontinuationSignificant delaySignificant reductionEstrogen
1979
Fibroadenoma in oral contraceptive users. A histopathologic evaluation of epithelial atypia
Livolsi V, Stadel B, Kelsey J, Holford T. Fibroadenoma in oral contraceptive users. A histopathologic evaluation of epithelial atypia. Cancer 1979, 44: 1778-1781. PMID: 498048, DOI: 10.1002/1097-0142(197911)44:5<1778::aid-cncr2820440535>3.0.co;2-y.Peer-Reviewed Original ResearchConceptsEpithelial atypiaLong-term usersOral contraceptivesOral contraceptive useOral contraceptive usersFibrocystic diseaseHistopathologic evaluationBreast diseaseContraceptive usersCytologic atypiaContraceptive useEpithelial componentAtypiaEpidemiological investigationsFibroadenomaDiseaseContraceptives